Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future

被引:676
作者
Arvizo, Rochelle R. [1 ]
Bhattacharyya, Sanjib [1 ]
Kudgus, Rachel A. [1 ]
Giri, Karuna [1 ]
Bhattacharya, Resham [1 ]
Mukherjee, Priyabrata [1 ,2 ,3 ]
机构
[1] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN 55905 USA
关键词
BRAIN-BARRIER PERMEABILITY; COATED GOLD NANOPARTICLES; IN-VIVO BIODISTRIBUTION; SILVER NANOPARTICLES; GREEN SYNTHESIS; PLATINUM NANOPARTICLES; PARTICLE-SIZE; OXIDATIVE STRESS; CELLULAR UPTAKE; COLLOIDAL GOLD;
D O I
10.1039/c2cs15355f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Biomedical nanotechnology is an evolving field having enormous potential to positively impact the health care system. Important biomedical applications of nanotechnology that may have potential clinical applications include targeted drug delivery, detection/diagnosis and imaging. Basic understanding of how nanomaterials, the building blocks of nanotechnology, interact with the cells and their biological consequences are beginning to evolve. Noble metal nanoparticles such as gold, silver and platinum are particularly interesting due to their size and shape dependent unique optoelectronic properties. These noble metal nanoparticles, particularly of gold, have elicited a lot of interest for important biomedical applications because of their ease of synthesis, characterization and surface functionalization. Furthermore, recent investigations are demonstrating another promising application of these nanomaterials as self-therapeutics. To realize the potential promise of these unique inorganic nanomaterials for future clinical translation, it is of utmost importance to understand a few critical parameters; (i) how these nanomaterials interact with the cells at the molecular level; (ii) how their biodistribution and pharmacokinetics influenced by their surface and routes of administration; (iii) mechanism of their detoxification and clearance and (iv) their therapeutic efficacy in appropriate disease model. Thus in this critical review, we will discuss the various clinical applications of gold, silver and platinum nanoparticles with relevance to above parameters. We will also mention various routes of synthesis of these noble metal nanoparticles. However, before we discuss present research, we will also look into the past. We need to understand the discoveries made before us in order to further our knowledge and technological development (318 references).
引用
收藏
页码:2943 / 2970
页数:28
相关论文
共 317 条
  • [1] The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity
    Abdelhalim, Mohamed Anwar K.
    Jarrar, Bashir M.
    [J]. LIPIDS IN HEALTH AND DISEASE, 2011, 10
  • [2] Preparation of silver nanoparticles in solution from a silver salt by laser irradiation
    Abid, JP
    Wark, AW
    Brevet, PF
    Girault, HH
    [J]. CHEMICAL COMMUNICATIONS, 2002, (07) : 792 - 793
  • [3] Synthesis and Bioconjugation of 2 and 3 nm-Diameter Gold Nanoparticles
    Ackerson, Christopher J.
    Jadzinsky, Pablo D.
    Sexton, Jonathan Z.
    Bushnell, David A.
    Kornberg, Roger D.
    [J]. BIOCONJUGATE CHEMISTRY, 2010, 21 (02) : 214 - 218
  • [4] Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles
    Agasti, Sarit S.
    Chompoosor, Apiwat
    You, Chang-Cheng
    Ghosh, Partha
    Kim, Chae Kyu
    Rotello, Vincent M.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (16) : 5728 - +
  • [5] Silver nanoparticle applications and human health
    Ahamed, Maqusood
    AlSalhi, Mohamad S.
    Siddiqui, M. K. J.
    [J]. CLINICA CHIMICA ACTA, 2010, 411 (23-24) : 1841 - 1848
  • [6] Shape-controlled synthesis of colloidal platinum nanoparticles
    Ahmadi, TS
    Wang, ZL
    Green, TC
    Henglein, A
    ElSayed, MA
    [J]. SCIENCE, 1996, 272 (5270) : 1924 - 1926
  • [7] Effect of Gold Nanoparticle Aggregation on Cell Uptake and Toxicity
    Albanese, Alexandre
    Chan, Warren C. W.
    [J]. ACS NANO, 2011, 5 (07) : 5478 - 5489
  • [8] Albini A., 2002, TUMORI S, V1, P9
  • [9] ANTONOVYCH TT, 1981, ANN CLIN LAB SCI, V11, P386
  • [10] Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells
    Arora, S.
    Jain, J.
    Rajwade, J. M.
    Paknikar, K. M.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 236 (03) : 310 - 318